Rapid safety assessment of a seasonal intradermal trivalent influenza vaccine

por Demeulemeester, Marc, Lavis, Nathalie, Balthazar, Yohan, Lechien, Patrice, Heijmans, Stéphane
Publicado 2016

Long-term outcome of the humoral and cellular immune response of an H5N1 adjuvanted influenza vaccine in elderly persons: 2-year follow-up of a randomised open-label study

por Gillard, Paul, Giet, Didier, Heijmans, Stéphane, Dramé, Mamadou, Walravens, Karl, Roman, François
Publicado 2014

Pneumococcal lower respiratory tract infections in adults: an observational case-control study in primary care in Belgium

por Flamaing, Johan, De Backer, Wilfried, Van Laethem, Yves, Heijmans, Stéphane, Mignon, Annick
Publicado 2015

Erratum to: Pneumococcal lower respiratory tract infections in adults: an observational case–control study in primary care in Belgium

por Flamaing, Johan, De Backer, Wilfried, Van Laethem, Yves, Heijmans, Stéphane, Mignon, Annick
Publicado 2016

Immunogenicity Profile of a 3.75-μg Hemagglutinin Pandemic rH5N1 Split Virion AS03(A)-Adjuvanted Vaccine in Elderly Persons: A Randomized Trial

por Heijmans, Stéphane, De Meulemeester, Marc, Reynders, Paul, Giet, Didier, Demanet, Etienne, Devresse, Pierre-Yves, Icardi, Giancarlo, Dramé, Mamadou, Roman, François, Gillard, Paul
Publicado 2011

Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial

por Beran, Jiri, Ambrozaitis, Arvydas, Laiskonis, Alvydas, Mickuviene, Narseta, Bacart, Patrick, Calozet, Yvan, Demanet, Etienne, Heijmans, Stephane, Van Belle, Paul, Weber, Françoise, Salamand, Camille
Publicado 2009

Prevalence of FRAX risk factors and the osteoporosis treatment gap among women ≥ 70 years of age in routine primary care across 8 countries in Europe

por McCloskey, Eugene, Rathi, Jeetandera, Heijmans, Stephane, Blagden, Mark, Cortet, Bernard, Czerwinski, Edward, Hadji, Peyman, Payer, Juraj, Palmer, Kerry, Stad, Robert, O’Kelly, James, Papapoulos, Socrates
Publicado 2022